Sharim Justin, Lo Wei-Lun, Kim Won, Chivukula Srinivas, Tenn Stephen, Kaprealian Tania, Pouratian Nader
David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California.
Department of Neurosurgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California; Division of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan; Doctoral Program for Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei, Taiwan.
Pract Radiat Oncol. 2017 Jul-Aug;7(4):221-227. doi: 10.1016/j.prro.2016.12.006. Epub 2016 Dec 23.
Stereotactic radiosurgery (SRS) provides a noninvasive treatment modality for patients with medically refractory trigeminal neuralgia. The root entry zone (REZ) has been proposed to be an ideal stereotactic target because it is partially composed of centrally produced myelin, conferring a theoretical increased sensitivity to irradiation as well as increased susceptibility to neurovascular conflict, making it the site in which nociceptive signals likely arise. The aim of this study is to determine if there is a statistically and clinically significant difference in pain relief or facial hypesthesia following SRS based on distance of the stereotactic isocenter from REZ.
Patients undergoing Novalis radiosurgery for the treatment of trigeminal neuralgia with at least 3 months' follow-up were included in this study. Postoperative outcomes were stratified by Barrow Neurological Institute (BNI) score for pain relief and BNI facial numbness score for facial hypesthesia.
Sixty-seven patients met inclusion criteria and were included in this study. BNI score of I-IIIa was attained in 82% of patients at 3 months and 65% at 1 year following SRS. Distance from isocenter to REZ varied from 0 to 8.6 mm, with a mean of 1.94 ± 1.62 mm. Logistic regression of target-REZ distance against pain relief outcome (patients with score I-IIIa and IIIb-V) was insignificant at 3 months (P = .988), 6 months (P = .925), 9 months (P = .845), and 12 months (P = .547) postoperatively. Furthermore, no significant correlation was found with logistic regression of target-REZ distance with pain relief outcome (patients with score I and score II-IV) (P = .544).
The current analysis suggests that distance from REZ does not correlate with degree of postoperative pain relief or facial hypesthesia; thus, targeting specific regions within the trigeminal nerve in relation to these anatomical characteristics may not afford any advantage from this perspective.
立体定向放射外科手术(SRS)为药物难治性三叉神经痛患者提供了一种非侵入性治疗方式。有人提出神经根入区(REZ)是理想的立体定向靶点,因为它部分由中枢产生的髓磷脂组成,理论上对辐射的敏感性增加,对神经血管冲突的易感性也增加,使其成为伤害性信号可能产生的部位。本研究的目的是确定基于立体定向等中心与REZ的距离,SRS术后疼痛缓解或面部感觉减退是否存在统计学和临床显著差异。
本研究纳入接受诺瓦利斯放射外科手术治疗三叉神经痛且随访至少3个月的患者。术后结果根据巴罗神经学研究所(BNI)疼痛缓解评分和BNI面部麻木评分进行分层。
67例患者符合纳入标准并纳入本研究。SRS术后3个月时82%的患者达到BNI I-IIIa级评分,1年时为65%。等中心到REZ的距离为0至8.6毫米,平均为1.94±1.62毫米。术后3个月(P = 0.988)、6个月(P = 0.925)、9个月(P = 0.845)和12个月(P = 0.547)时,目标-REZ距离与疼痛缓解结果(I-IIIa级和IIIb-V级评分患者)的逻辑回归无显著意义。此外,目标-REZ距离与疼痛缓解结果(I级和II-IV级评分患者)的逻辑回归未发现显著相关性(P = 0.544)。
目前的分析表明,与REZ的距离与术后疼痛缓解程度或面部感觉减退无关;因此,从这个角度来看,根据这些解剖特征靶向三叉神经内的特定区域可能没有任何优势。